Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Year-over-year gross profit growth rate
Latest
-65.98%
↓ 510% below average
Average (9y)
16.10%
Historical baseline
Range
High:255.11%
Low:-124.54%
CAGR
+20.4%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | -65.98% |
| 2023 | -53.51% |
| 2022 | 255.11% |
| 2021 | 127.09% |
| 2020 | 21.37% |
| 2019 | 0.79% |
| 2018 | 0.00% |
| 2017 | 13.04% |
| 2016 | -124.54% |
| 2015 | -12.37% |